In agreement with our data, resistin levels were stable after 2 days and 2 months of CPAP use in a group of subjects with OSA, suggesting that resistin is unlikely to play an important role in the insulin resistance or obesity seen in OSA [13]. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.